Skip to main content

Advertisement

Log in

Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A fast gas chromatography (GC)-MS method has been developed and validated for the simultaneous screening of different classes of drugs of abuse in urine. Tetrahydrocannabinol metabolite, cocaine, opiates such as morphine, O-6-monoacetylmorphine (O-6-MAM), codeine, opioids such as buprenorphine, methadone, pentazocine, fentanyl and analogues and their main metabolites can be detected and quantified after a simple liquid–liquid extraction in alkaline conditions and derivatisation to obtain the corresponding trimethylsilyl derivatives. The chromatographic separation is performed in a total time of 6 min, using a short GC column (5% phenyl methyl silicone, 10-m length × 0.18-mm internal diameter). The Limits of Detection are satisfactory for forensic purposes for all the substances; the repeatability of concentrations (percent coefficients of variation) are always lower than 15% at high and low concentration levels, and accuracy, intended as % error on the true value, is always lower than 15% for all the analytes. The method can successfully be applied for screening analyses in many fields of forensic toxicology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bush DM (2008) The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Forensic Sci Int 174:111–119

    Article  Google Scholar 

  2. Lillsunde P, Haavanlammi K, Partinen R, Mukala K, Lamberg M (2008) Finnish guidelines for workplace drug testing. Forensic Sci Int 174:99–102

    Article  Google Scholar 

  3. Fraser AD, Zamecnik J (2002) Substance abuse monitoring by the Correctional Service of Canada. Ther Drug Monit 24:187–191

    Article  Google Scholar 

  4. Rohrig TP, Moore C (2003) The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol 27:449–452

    CAS  Google Scholar 

  5. Verstraete AG, Pierce A (2001) Workplace drug testing in Europe. Forensic Sci Int 121:2–6

    Article  CAS  Google Scholar 

  6. European Workplace Drug Testing Society (2002) European Laboratory Guidelines for Legally Defensible Workplace Drug Testing. Available at: http://www.ewdts.org/guidelines/EWDTSGuidelines.pdf. Accessed 15 June 2010.

  7. U.S. Substance Abuse and Mental Health Services Administration (2004) Mandatory Guidelines for Federal Workplace Drug Testing Program. Available at: http://www.workplace.samhsa.gov. Accessed 15 June 2010

  8. Marquet P, Delpla PA, Kerguelen S, Bremond J, Facy F, Garnier M, Guery B, Lhermitte M, Mathé D, Pelissier AL, Renaudeau C, Vest P, Seguela JP (1998) Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study. J Forensic Sci 43:806–811

    CAS  Google Scholar 

  9. Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG (2004) Drugs and driving. Traffic Inj Prev 5:241–253

    Article  Google Scholar 

  10. Jönsson AK, Holmgren P, Druid H, Ahlner J (2007) Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002–2003. Forensic Sci Int 169:101–107

    Article  Google Scholar 

  11. Lehrmann E, Afanador ZR, Deep-Soboslay A, Gallegos G, Darwin WD, Lowe RH, Barnes AJ, Huestis MA, Cadet JL, Herman MM, Hyde TM, Kleinman JE, Freed WJ (2008) Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol 13:105–112

    Article  Google Scholar 

  12. World Anti-Doping Agency, Montreal (Canada) (2010) The World Anti-Doping Code. The 2010 Prohibited List International Standard. Available at: http://www.wada-ama.org. Accessed 15 June 2010.

  13. López P, Bermejo AM, Tabernero MJ, Cabarcos P, Alvarez I, Fernández P (2009) Cocaine and opiates use in pregnancy: detection of drugs in neonatal meconium and urine. J Ana Toxicol 33:351–355

    Google Scholar 

  14. Ferrara SD, Tedeschi L, Frison G, Brusini G, Castagna F, Bernardelli B, Soregaroli D (1994) Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol 18:278–291

    CAS  Google Scholar 

  15. Garcia-Jimenez S, Heredia-Lezama K, Bilbao-Marcos F, Fuentes-Lara G, Monroy-Noyola A, Deciga-Campos M (2008) Screening for marijuana and cocaine abuse by immunoanalysis and gas chromatography. Ann NY Acad Sci 1139:422–425

    Article  CAS  Google Scholar 

  16. von Mach M, Weber C, Meyer MR, Weilemann LS, Maurer HH, Peters FT (2007) Comparison of urinary on-site immunoassay screening and gas chromatography–mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit 29:27–39

    Article  Google Scholar 

  17. Kyle PB, Spencer JL, Purser CM, Eddleman KC, Hume AS (2003) Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals. J Toxicol Clin Toxicol 41:919–925

    Article  CAS  Google Scholar 

  18. World Anti-Doping Agency (2010) WADA Technical Document-TD2010IDCR. Available at: http://www.wada-ama.org. Accessed 15 September 2010.

  19. Langman LJ, Bjergum MW, Williamson CL, Crow FW (2009) Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine. J Anal Toxicol 33:447–455

    CAS  Google Scholar 

  20. Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC (2009) Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem 42:1531–1542

    Article  CAS  Google Scholar 

  21. De Giovanni N, Strano-Rossi S (1994) Simultaneous detection of cocaine and heroin metabolites in urine by solid phase extraction and GC/MS. J Chromatogr B 658:69–73

    Article  Google Scholar 

  22. Strano Rossi S, Molaioni F, Botrè F (2005) Application of solid-phase microextraction to antidoping analysis: determination of stimulants, narcotics, and other classes of substances excreted free in urine. J Anal Toxicol 29:217–222

    CAS  Google Scholar 

  23. Strano Rossi S, Molaioni F, Rossi F, Botrè F (2005) Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis. Rapid Comm Mass Spectrom 19:1529–1535

    Article  CAS  Google Scholar 

  24. Gallardo E, Barroso M, Queiroz JA (2009) LC-MS: a powerful tool in workplace drug testing. Drug Test Anal 1:109–115

    Article  CAS  Google Scholar 

  25. Rittner M, Pragst F, Bork W, Neumann J (2001) Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography–electrospray ionization mass spectrometry. J Anal Toxicol 25:115–124

    CAS  Google Scholar 

  26. Adamowicz P, Kała M (2010) Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography–electron ionization-mass spectrometry. Forensic Sci Int 198:39–45

    Article  CAS  Google Scholar 

  27. van Thuyne W, Van Eenoo P, Delbeke FT (2008) Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis. J Chrom A 1210:193–202

    Article  Google Scholar 

  28. Thevis M, Schänzer W (2007) Current role of LC–MS(/MS) in doping control. Anal Bioanal Chem 388:1351–1358

    Article  CAS  Google Scholar 

  29. WADA Technical Document-TD2010MRPL (2010). Available at: http://www.wada-ama.org. Accessed 15 September 2010.

  30. Mazzarino M, Orengia M, Botrè F (2007) Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis. Rapid Commun Mass Spectrom 21:4117–4124

    Article  CAS  Google Scholar 

  31. Morra V, Davit P, Capra P, Vincenti M, Di Stilo A, Botrè F (2006) Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis. J Chromatogr A 1135:219–229

    Article  CAS  Google Scholar 

  32. Húsková R, Matisová E, Hrouzková S, Svorc L (2009) Analysis of pesticide residues by fast gas chromatography in combination with negative chemical ionization mass spectrometry. J Chromatogr A 1216:6326–6334

    Article  Google Scholar 

  33. Strano Rossi S, de la Torre X, Botrè F (2010) A fast GC-MS method for the determination of stimulants and narcotics in urine. Rapid Commun Mass Spectrom 24:1475–1480

    Article  Google Scholar 

  34. Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224

    Article  CAS  Google Scholar 

  35. World Anti-Doping Agency (2009) International Standard for Laboratories. Available at: http://www.wada-ama.org. Accessed 15 September 2010.

  36. U.S. Department of Health and Human Services Food and Drug Administration (2001) Bioanalytical methods validation. Available at: http://www.fda.gov/downloads/drugs. Accessed 17 November 2010

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sabina Strano-Rossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strano-Rossi, S., Bermejo, A.M., de la Torre, X. et al. Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine. Anal Bioanal Chem 399, 1623–1630 (2011). https://doi.org/10.1007/s00216-010-4471-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-010-4471-4

Keywords

Navigation